prolaio eVO2peak Module vs LINQ II Insertable Cardiac Monitor

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

prolaio eVO2peak Module

by Prolaio

LINQ II Insertable Cardiac Monitor

by Medtronic

AI Verdict

While both are FDA-cleared AI tools categorized under Cardiology AI and Clinical Decision Support, they serve distinct purposes. Prolaio eVO2peak Module is a software solution that estimates peak oxygen consumption using data from external wearable sensors, primarily for cardiovascular fitness assessment and research. In contrast, the Medtronic LINQ II is an insertable cardiac monitor designed for long-term, continuous heart rhythm monitoring and arrhythmia diagnosis through an implanted device.

Choose prolaio eVO2peak Module if…

Choose Prolaio eVO2peak Module if you need a non-invasive, software-only solution to estimate peak oxygen consumption (eVO2peak) for adult patients. It is ideal for cardiovascular research or ongoing patient management, utilizing data from qualified third-party FDA-cleared wearable medical sensors to provide high-density, longitudinal insights into cardiorespiratory fitness as an adjunctive aid in clinical evaluation.

View prolaio eVO2peak Module →

Choose LINQ II Insertable Cardiac Monitor if…

Choose Medtronic LINQ II Insertable Cardiac Monitor if you require long-term, continuous, and highly accurate heart rhythm monitoring for diagnosing infrequent or asymptomatic arrhythmias in adult and pediatric patients (ages 2+). This insertable device offers up to 4.5 years of monitoring with AI-powered accuracy and remote management, making it suitable when extended, uninterrupted data collection is crucial for diagnosis.

View LINQ II Insertable Cardiac Monitor →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	prolaio eVO2peak Module	LINQ II Insertable Cardiac Monitor
Deployment	Cloud	Subcutaneous implant with remote monitoring via mobile app or home communicator.
FDA Status	Cleared AI-estimated	Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

prolaio eVO2peak Module

Tool A, the Prolaio eVO2peak Module, is a software-only solution that processes data from remote, third-party wearable sensors. This non-invasive approach generally implies a lower burden for patients (no surgical implant) and potentially simpler integration into existing clinical workflows for data analysis compared to managing an implanted device.

Clinical Value

LINQ II Insertable Cardiac Monitor

The Medtronic LINQ II provides long-term, continuous heart rhythm monitoring with AI-powered accuracy for diagnosing arrhythmias, which are often acute and require direct intervention. Its ability to directly diagnose specific cardiac conditions, coupled with a pediatric indication and extended monitoring duration, offers a more immediate and impactful clinical value for actionable diagnoses compared to Tool A's adjunctive estimation of eVO2peak.

Pricing & Value

Tie

Both tools lack transparent public pricing, with both requiring direct contact or enterprise negotiation. Without specific pricing details or cost-effectiveness studies, it is impossible to definitively compare their value propositions.

Enterprise Readiness

LINQ II Insertable Cardiac Monitor

Medtronic (Tool B) is a globally established medical device company founded in 1949, with over a million patients having received their ICMs worldwide. This extensive history, global presence, and vast customer base indicate a highly robust infrastructure for enterprise-level deployment, support, and integration, surpassing the information available for Prolaio (Tool A).

Innovation

prolaio eVO2peak Module

Tool A's innovation lies in its use of a locked deep-learning model to estimate peak oxygen consumption (eVO2peak) from non-invasive, real-world data from third-party wearable sensors. This approach offers a novel and potentially more accessible method for obtaining a critical physiological marker, representing a significant shift in non-invasive physiological assessment.

Support & Docs

LINQ II Insertable Cardiac Monitor

While specific details on support and documentation are not provided for either tool, Medtronic (Tool B) is a large, long-standing global medical device company. Based on its size, history, and extensive market penetration, it is highly probable that Medtronic offers comprehensive and well-established support infrastructure, training programs, and documentation for its products.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	prolaio eVO2peak Module	LINQ II Insertable Cardiac Monitor
Product Name	prolaio eVO2peak Module	LINQ II Insertable Cardiac Monitor
Company	Prolaio	Medtronic
Primary Function	Estimates peak oxygen consumption (eVO2peak) using real-world patient data for cardiovascular research and care.	Long-term, continuous heart rhythm monitoring with remote programming and enhanced accuracy for diagnosing arrhythmias.
AI/Algorithm Use	Applies a locked deep-learning model for eVO2peak estimation	AccuRhythmu2122 AI algorithms for enhanced accuracy
Key Data Input/Monitoring	Utilizes demographic data, single-lead ECG, and triaxial accelerometry inputs from qualified third-party FDA-cleared wearable medical sensors	Up to 4.5 years of continuous monitoring; MyCareLink Heartu2122 mobile app for data transmission
Specialties	Cardiology, Physical Medicine & Rehab, Sports Medicine	Cardiology

Videos

Demos, reviews, and walkthroughs featuring prolaio eVO2peak Module and LINQ II Insertable Cardiac Monitor.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary clinical purpose and output of each tool?

The Prolaio eVO2peak Module is FDA-cleared software intended for estimating peak oxygen consumption (eVO2peak) in adult patients, serving as an adjunctive aid in clinical evaluation for cardiovascular research and care. The Medtronic LINQ II Insertable Cardiac Monitor provides long-term, continuous heart rhythm monitoring with enhanced accuracy for diagnosing arrhythmias in adult and pediatric patients aged 2 and older.

How do the data collection methods and device types differ between the Prolaio eVO2peak Module and the Medtronic LINQ II?

The Prolaio eVO2peak Module is a cloud-based software-only solution that processes data from qualified third-party FDA-cleared wearable medical sensors. In contrast, the Medtronic LINQ II is an insertable cardiac monitor, a small device placed just under the skin, that provides continuous monitoring from an implanted device.

What specific patient data inputs are required or utilized by each tool?

The Prolaio eVO2peak Module utilizes demographic data, single-lead ECG, and triaxial accelerometry inputs from remote sensors worn by patients during activities of daily living. The Medtronic LINQ II, as an insertable device, continuously records subcutaneous ECG for heart rhythm monitoring.

What is the typical duration or nature of monitoring provided by each tool?

The Prolaio eVO2peak Module enables high-density, longitudinal data collection from remote sensors. The Medtronic LINQ II Insertable Cardiac Monitor offers up to 4.5 years of continuous heart rhythm monitoring from its implanted device.

For which medical specialties and patient populations is each tool indicated?

The Prolaio eVO2peak Module is relevant for Cardiology, Physical Medicine & Rehab, and Sports Medicine. The Medtronic LINQ II is primarily for Cardiology and has an expanded indication for pediatric patients aged 2 and up.

How is artificial intelligence (AI) utilized in each of these tools?

The Prolaio eVO2peak Module applies a locked deep-learning model and proprietary algorithms for eVO2peak estimation. The Medtronic LINQ II features AccuRhythm AI algorithms for enhanced accuracy in diagnosing arrhythmias, specifically reducing false alerts for atrial fibrillation and pause.